Clinical Trial Update: Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating precision adjuvant therapy after surgery for hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Chen Xiaoping | Conditions: HCC | Phase 4 | Status: RECRUITING